At a glance
ClinicalIndex Comparison RecordN/ACompleted· 145 enrolled
Drug / intervention
Parietene DS Composite Meshdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center Post-market Single Arm Prospective Study of Parietene™ DS Composite Mesh in Subjects Undergoing Ventral Hernia Repair
In Brief
A clinical study evaluating Parietene DS Composite Mesh for Ventral Hernia. Completed, enrolled 145 participants across 6 sites.
Detailed Summary
A multi-center post-market single arm prospective study of Parietene™ DS Composite Mesh in subjects undergoing ventral hernia repair to confirm its clinical safety and performance in the short (1, 3 months), mid (12 months) and long term (24 months)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentral Hernia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2018
Enrollment StartJun 2018
Primary CompletionJul 2021
Study CompletionJul 2022
TodayJul 2026
First PostedApr 11, 2018
Enrollment StartJun 21, 2018
Primary CompletionJul 21, 2021
Study CompletionJul 6, 2022
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 8.2 years ago
Interventions
Parietene DS Composite Meshdevice
All subjects enrolled will receive the Parietene DS Composite Mesh